Viewing nowPregatin Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 201109307 · Approved 2011.10.31 · Insurance code 657804790
Treatment of neuropathic pain, adjunctive treatment of partial-onset seizures, treatment of fibromyalgia
This medication is used in adults for the treatment of peripheral and central neuropathic pain. It can also be used as an adjunctive therapy in patients with epilepsy who have partial seizures or secondary generalized symptoms. Additionally, it helps to relieve pain associated with fibromyalgia. It is effectively used in the treatment of various neurological disorders.
This medicine is administered orally, with or without food, in 2 divided doses of the total daily dose of pregabalin. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See “5. Patients with Renal Impairment”) 1. Neuropathic Pain 1) Peripheral Neuropathic Pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of the individual patient, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may thereafter be increased at 7-day intervals up to a maximum of 600 mg/day. 2) Central Neuropathic Pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of the individual patient, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See “4. Discontinuation of Treatment”) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of the individual patient, the dose may be increased to 300 mg/day after 1 week. If necessary, it may thereafter be increased at 7-day intervals up to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg to 450 mg/day. The initial dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this medicine is primarily excreted by the kidneys as unchanged drug. Since the clearance of this medicine is directly affected by creatinine clearance, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. For women, multiply the result obtained from the above equation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin Dosage Based on Renal Function Creatinine clearance (CLcr), (mL/min) ≥60: Starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥30 -<60: Starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥15 -<30: Starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr), (mL/min) <15: Starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: Starting dose 25, maximum dose 100, single dose TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified in the administration schedule. b: The supplemental dose refers to an additional dose administered as a single dose. 6. Patients with Hepatic Impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older Adults (aged 65 years and older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient data on safety and efficacy. Adolescent patients aged 12 to 17 years: Administration is not recommended because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behaviors, so patients taking it should inform their healthcare provider if they experience depression or mood changes. Patients with allergies to any components of this medication, or those with specific genetic issues such as lactose intolerance, should not use it. Diabetic patients should monitor their blood sugar levels closely as this medication can cause weight gain and changes in blood glucose levels. In case of severe allergic reactions such as angioedema, patients should stop taking the medication immediately and consult their healthcare provider. Elderly patients may experience increased dizziness or sedation, which could heighten the risk of falls and other accidents; caution is advised. Visual disturbances may occur; if symptoms arise, patients should inform their healthcare provider. Abrupt discontinuation of this medication can lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so it should be tapered off gradually according to the healthcare provider's instructions. There is a risk of drug abuse, so patients with a history of substance abuse should take this medication with caution and report any signs of abuse immediately. Patients with decreased kidney function may require dosage adjustments. Patients with heart disease should consult their healthcare provider before taking this medication, especially those with severe heart failure. Caution is required if taking this medication alongside opioid analgesics due to an increased risk of central nervous system and respiratory depression. During early pregnancy, there is a risk of fetal malformations, so women who are pregnant or planning to become pregnant should consult their healthcare provider before taking this medication and should use effective contraceptive methods. Women who are breastfeeding should consider discontinuing either breastfeeding or the medication, as this drug can be passed into breast milk. Dizziness and sedation are common, so patients should avoid driving or operating hazardous machinery until they are sure of how the medication affects them. In case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, so patients should seek appropriate medical treatment immediately. This medication should be kept out of reach of children, and transferring it to other containers should be avoided.
Suicidal ideation, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, periorbital swelling, upper airway swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorder, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, pain, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, decreased appetite, hypoglycemia, confusion, spatial disorientation, irritability, euphoria, decreased libido, depersonalization, paraphilia, anxiety, mood disturbance, emotional blunting, emotional elevation, difficulty finding appropriate terminology, hallucinations, abnormal dreams, increased libido, panic attacks, disinhibition, apathy, ataxia, movement coordination disorder, balance disorder, amnesia, attention deficit, memory impairment, tremor, dysarthria, sensory disturbance, sensory loss, sedation, drowsiness, cognitive impairment, nystagmus, language disorder, myoclonus, decreased reflexes, movement disorder, psychomotor agitation, orthostatic dizziness, hyperesthesia, burning sensation, activity tremor, syncope, confusion, hypokinesia, olfactory disturbance, loss of taste, writing difficulty, blurred vision, diplopia, indirect vision loss, visual impairment, visual field deficit, photophobia, dry eyes, eye edema, decreased vision, eye pain, eye fatigue, increased tear production, eye irritation, mydriasis, during vibration, changes in depth perception, strabismus, brightness of vision, vertigo, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, sialorrhea, gastroesophageal reflux disease, oral sensory reduction, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweat, muscle cramps, arthralgia, back pain, limb pain, cervical cramps, joint swelling, myalgia, muscle spasm, neck pain, muscle rigidity, rhabdomyolysis, urinary disorders, urinary incontinence, reduced urine output, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, nipple discharge, breast enlargement, peripheral edema, edema, gait disturbance, falls, feeling drunk, altered sensation, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, increased blood sugar, decreased platelet count, decreased serum potassium, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reaction, headache, keratitis, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, shock, anaphylaxis-like symptoms, skin-mucous membrane syndrome, erythema multiforme, delirium, paralysis, affective disorder, sleepiness, state of confusion, agitation, restlessness, seizures, ataxia, speech disorder, bloody stools, increased BUN, urinary difficulty, tinnitus, skin diseases
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or humidity. It is best to maintain storage temperatures between 15 and 30 degrees Celsius.
A hard capsule with a red-brown upper part and a white lower part containing a white powder that is white or pale yellow.
30 capsules/bottle, 200 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Hana Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.